Americans are still looking for ways to confront the rising cost of prescription drugs.
According to a new poll by the Kaiser Family Foundation, 60% of the roughly 1,100 people who responded to the survey consider lowering the cost of prescriptions a priority at the national level.
One of way to tackle the issue that has overwhelming support: allowing the government to negotiate drug prices with drugmakers for Medicare. According to the poll, 92% of Americans are in favour of allowing the government these Medicare negotiations. That response was consistent across party lines: 92% of Republicans, 92% of Independents, and 96% of Democrats were in favour of drug price negotiations.
The government currently can’t negotiate prices for drugs that are part of Medicare’s Part D program, which covers most prescription drugs. Exactly what it would look like if the government could negotiate prices wasn’t included in the survey.
It’s a topic that’s been on President Donald Trump’s radar. At a January news conference, Trump said drugmakers are “getting away with murder,” and expressed an interest in negotiating drug prices.
In March, the president met with Reps. Elijah Cummings and Peter Welch to talk about drug pricing, where the representatives showed Trump a bill that would allow Medicare to negotiate lower drug prices.
And it wasn’t just Medicare negotiations that the survey respondents supported. Americans also overwhelmingly supported having drug companies release information on how they set the prices on drugs, placing limits on how much companies can charge, and even importing drugs from Canada.